Results 181 to 190 of about 8,662,910 (358)

Editorial Team

open access: yesDrug Analytical Research, 2021
Drug Analytical Research
doaj  

Publisher Correction: Inhaled biologics for respiratory diseases: clinical potential and emerging technologies. [PDF]

open access: yesDrug Deliv Transl Res
Shaibie NA   +4 more
europepmc   +1 more source

Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells [PDF]

open access: bronze, 2015
Sarah A. Head   +14 more
openalex   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

The Emergence of Novel Benzodiazepines in Australia, Evidence, Alerts, Clinical Management and Harm Reduction-A Narrative Review. [PDF]

open access: yesDrug Alcohol Rev
Freestone J   +13 more
europepmc   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Editorial

open access: yesDrug Analytical Research, 2022
Drug Analytical Research
doaj  

Home - About - Disclaimer - Privacy